- Home
- TLRY vs PDT Comparison
TLRY vs PDT Comparison
Compare TLRY & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLRY
- PDT
- Stock Information
- Founded
- TLRY N/A
- PDT 1989
- Country
- TLRY Canada
- PDT United States
- Employees
- TLRY N/A
- PDT N/A
- Industry
- TLRY Medicinal Chemicals and Botanical Products
- PDT Finance Companies
- Sector
- TLRY Health Care
- PDT Finance
- Exchange
- TLRY Nasdaq
- PDT Nasdaq
- Market Cap
- TLRY 708.1M
- PDT 644.8M
- IPO Year
- TLRY 2018
- PDT N/A
- Fundamental
- Price
- TLRY $0.61
- PDT $13.34
- Analyst Decision
- TLRY Hold
- PDT
- Analyst Count
- TLRY 3
- PDT 0
- Target Price
- TLRY $1.38
- PDT N/A
- AVG Volume (30 Days)
- TLRY 49.5M
- PDT 145.6K
- Earning Date
- TLRY 07-28-2025
- PDT 01-01-0001
- Dividend Yield
- TLRY N/A
- PDT 8.88%
- EPS Growth
- TLRY N/A
- PDT N/A
- EPS
- TLRY N/A
- PDT N/A
- Revenue
- TLRY $821,309,000.00
- PDT N/A
- Revenue This Year
- TLRY $8.95
- PDT N/A
- Revenue Next Year
- TLRY $4.76
- PDT N/A
- P/E Ratio
- TLRY N/A
- PDT N/A
- Revenue Growth
- TLRY 4.10
- PDT N/A
- 52 Week Low
- TLRY $0.35
- PDT $8.77
- 52 Week High
- TLRY $2.15
- PDT $13.05
- Technical
- Relative Strength Index (RSI)
- TLRY 51.85
- PDT 59.11
- Support Level
- TLRY $0.55
- PDT $13.22
- Resistance Level
- TLRY $0.83
- PDT $13.38
- Average True Range (ATR)
- TLRY 0.06
- PDT 0.13
- MACD
- TLRY -0.01
- PDT 0.00
- Stochastic Oscillator
- TLRY 22.29
- PDT 89.19
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.